Indofarma Tbk Stock Price To Book
| INAF Stock | IDR 130.00 2.00 1.52% |
Indofarma Tbk fundamentals help investors to digest information that contributes to Indofarma Tbk's financial success or failures. It also enables traders to predict the movement of Indofarma Stock. The fundamental analysis module provides a way to measure Indofarma Tbk's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Indofarma Tbk stock.
Indofarma |
Indofarma Tbk Company Price To Book Analysis
Indofarma Tbk's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Indofarma Tbk Price To Book | 8.91 X |
Most of Indofarma Tbk's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Indofarma Tbk is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Indofarma Tbk has a Price To Book of 8.9113 times. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to book for all Indonesia stocks is notably lower than that of the firm.
Indofarma Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Indofarma Tbk's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Indofarma Tbk could also be used in its relative valuation, which is a method of valuing Indofarma Tbk by comparing valuation metrics of similar companies.Indofarma Tbk is currently under evaluation in price to book category among related companies.
Indofarma Fundamentals
| Return On Equity | -0.59 | |||
| Return On Asset | -0.0451 | |||
| Profit Margin | (0.1) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 3.17 T | |||
| Shares Outstanding | 3.1 B | |||
| Shares Owned By Insiders | 88.00 % | |||
| Price To Book | 8.91 X | |||
| Price To Sales | 1.25 X | |||
| Revenue | 2.9 T | |||
| Gross Profit | 442.87 B | |||
| EBITDA | 70.22 B | |||
| Net Income | (37.58 B) | |||
| Total Debt | 397.52 B | |||
| Book Value Per Share | 104.92 X | |||
| Cash Flow From Operations | 92.9 B | |||
| Earnings Per Share | (29.18) X | |||
| Number Of Employees | 1.18 K | |||
| Beta | -0.22 | |||
| Market Capitalization | 2.59 T | |||
| Total Asset | 2.01 T | |||
| Z Score | 4.6 | |||
| Net Asset | 2.01 T |
About Indofarma Tbk Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Indofarma Tbk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Indofarma Tbk using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Indofarma Tbk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Indofarma Tbk in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Indofarma Tbk's short interest history, or implied volatility extrapolated from Indofarma Tbk options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indofarma Tbk. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Indofarma Stock analysis
When running Indofarma Tbk's price analysis, check to measure Indofarma Tbk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indofarma Tbk is operating at the current time. Most of Indofarma Tbk's value examination focuses on studying past and present price action to predict the probability of Indofarma Tbk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indofarma Tbk's price. Additionally, you may evaluate how the addition of Indofarma Tbk to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |